Abiopharma

Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma

PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference

CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath

First Patient Dosed in SAB BIO’s SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D

Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform

Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development

Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Disease Registry to Advance Real-World Evidence in Neurodegenerative Care

Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

Cybin - Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq